SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Corteva, Inc., et al. – ‘10-Q’ for 3/31/20 – ‘EX-10.4’

On:  Thursday, 5/7/20, at 1:41pm ET   ·   For:  3/31/20   ·   Accession #:  1755672-20-14   ·   File #s:  1-00815, 1-38710

Previous ‘10-Q’:  ‘10-Q’ on 10/31/19 for 9/30/19   ·   Next:  ‘10-Q’ on 8/6/20 for 6/30/20   ·   Latest:  ‘10-Q’ on 5/2/24 for 3/31/24   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/07/20  Corteva, Inc.                     10-Q        3/31/20  123:15M
          Dupont E I De Nemours & Co

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.77M 
 2: EX-10.1     Material Contract                                   HTML    183K 
 3: EX-10.2     Material Contract                                   HTML    252K 
 4: EX-10.3     Material Contract                                   HTML     63K 
 5: EX-10.4     Material Contract                                   HTML     72K 
 6: EX-10.5     Material Contract                                   HTML     68K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     49K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     49K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     37K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     37K 
95: R1          DEI Document                                        HTML    111K 
24: R2          Consolidated Statements of Operations               HTML    122K 
68: R3          Consolidated Statements of Comprehensive (Loss)     HTML     68K 
                Income                                                           
107: R4          Consolidated Balance Sheets                         HTML    175K  
97: R5          Consolidated Balance Sheets (Parentheticals)        HTML     59K 
26: R6          Consolidated Statements of Cash Flows               HTML    143K 
70: R7          Statement of Stockholders Equity Statement          HTML     86K 
108: R8          Statement of Stockholders' Equity Parentheticals    HTML     39K  
                (Parentheticals)                                                 
92: R9          Summary of Significant Accounting Policies (Notes)  HTML     42K 
33: R10         Recent Accounting Guidance                          HTML     40K 
47: R11         Divestitures and Other Transactions                 HTML    116K 
110: R12         Revenue (Notes)                                     HTML     94K  
72: R13         Restructuring and Asset Related Charges             HTML     88K 
34: R14         Related Party Transactions (Notes)                  HTML     37K 
49: R15         Supplementary Information                           HTML     87K 
111: R16         Income Taxes                                        HTML     38K  
73: R17         Earnings Per Share (Notes)                          HTML     72K 
32: R18         Accounts and Notes Receivable (Notes)               HTML     61K 
50: R19         Inventories                                         HTML     45K 
105: R20         Other Intangible Assets                             HTML    115K  
94: R21         Short-Term Borrowings, Long-Term Debt and           HTML     61K 
                Available Credit Facilities                                      
25: R22         Commitments and Contingent Liabilities              HTML    100K 
69: R23         Stockholders' Equity                                HTML    119K 
106: R24         Pension Plans and Other Post Employment Benefit     HTML     55K  
                Plans                                                            
96: R25         Financial Instruments                               HTML    179K 
27: R26         Fair Value Measurements                             HTML     66K 
71: R27         Segment Reporting (Notes)                           HTML    120K 
109: R28         EID - Basis of Presentation (Notes)                 HTML     53K  
93: R29         EID - Related Party Transactions (Notes)            HTML     44K 
75: R30         EID Segment FN (Notes)                              HTML    142K 
114: R31         Summary of Significant Accounting Policies          HTML     41K  
                (Policies)                                                       
45: R32         Recent Accounting Guidance Recent Accounting        HTML     40K 
                Guidance (Policies)                                              
31: R33         Revenue Revenue Recognition (Policies)              HTML     38K 
74: R34         Divestitures and Other Transactions (Tables)        HTML    125K 
113: R35         Revenue (Tables)                                    HTML     93K  
44: R36         Restructuring and Asset Related Charges (Tables)    HTML     84K 
30: R37         Supplementary Information (Tables)                  HTML     90K 
76: R38         Earnings Per Share (Tables)                         HTML     81K 
112: R39         Accounts and Notes Receivable (Tables)              HTML     58K  
86: R40         Inventories (Tables)                                HTML     46K 
100: R41         Other Intangible Assets (Tables)                    HTML    112K  
67: R42         Short-Term Borrowings, Long-Term Debt and           HTML     50K 
                Available Credit Facilities Debt (Tables)                        
23: R43         Commitments and Contingent Liabilities (Tables)     HTML     55K 
85: R44         Stockholders' Equity (Tables)                       HTML    126K 
99: R45         Pension Plans and Other Post Employment Benefit     HTML     55K 
                Plans (Tables)                                                   
66: R46         Financial Instruments (Tables)                      HTML    175K 
22: R47         Fair Value Measurements (Tables)                    HTML     65K 
87: R48         Segment Reporting (Tables)                          HTML    125K 
98: R49         EID Segment FN (Tables)                             HTML     74K 
115: R50         Summary of Significant Accounting Policies Summary  HTML     33K  
                of Accounting Policies (Details)                                 
78: R51         Divestitures and Other Transactions Separation      HTML     50K 
                Agreements (Details)                                             
41: R52         Divestitures and Other Transactions Divestitures    HTML    182K 
                and Other Transactions - ECP Divestiture (Details)               
57: R53         Divestitures and Other Transactions Divestitures    HTML    186K 
                and Other Transactions - SP Divestiture (Details)                
117: R54         Revenue Narrative (Details)                         HTML     41K  
80: R55         Revenue Contract Balances (Details)                 HTML     51K 
43: R56         Revenue Disaggregation of Revenue - Principal       HTML     55K 
                Product Groups (Details)                                         
59: R57         Revenue Disaggregation of Revenue - Geography       HTML     54K 
                (Details)                                                        
118: R58         Restructuring and Asset Related Charges Execute to  HTML     72K  
                Win Productivity Program (Details)                               
77: R59         Restructuring and Asset Related Charges DowDuPont   HTML     66K 
                Cost Synergy Program (Details)                                   
18: R60         Restructuring and Asset Related Charges Narrative   HTML     38K 
                (Details)                                                        
60: R61         Related Party Transactions Dow Intercompany         HTML     35K 
                Transactions (Details)                                           
101: R62         Related Party Transactions Transactions with        HTML     41K  
                DowDuPont (Details)                                              
88: R63         Supplementary Information Other Income (Expense) -  HTML     54K 
                Net (Details)                                                    
21: R64         Supplementary Information Foreign Currency          HTML     45K 
                Exchange Gain (Loss) (Details)                                   
63: R65         Supplementary Information Reconciliation of Cash,   HTML     60K 
                Cash Equivalents and Restricted Cash (Details)                   
104: R66         Income Taxes Income Tax Narrative (Details)         HTML     36K  
91: R67         Earnings Per Share Narrative (Details)              HTML     36K 
16: R68         Earnings Per Share Net Income for Earnings Per      HTML     59K 
                Share Calculations - Basic and Diluted (Details)                 
64: R69         Earnings Per Share Earnings Per Share Calculations  HTML     43K 
                - Basic (Details)                                                
56: R70         Earnings Per Share Earnings Per Share Calculations  HTML     43K 
                - Diluted (Details)                                              
38: R71         Earnings Per Share Share Count Information          HTML     52K 
                (Details)                                                        
84: R72         Accounts and Notes Receivable (Details)             HTML     68K 
122: R73         Accounts and Notes Receivable Allowance             HTML     43K  
                Rollforward (Details)                                            
53: R74         Inventories Schedule of Inventory (Details)         HTML     48K 
35: R75         Property, Plant and Equipment Schedule of           HTML     36K 
                Property, Plant and Equipment (Details)                          
81: R76         Other Intangible Assets Other Intangible Assets     HTML     80K 
                (Details)                                                        
119: R77         Other Intangible Assets Future Amortization         HTML     53K  
                Expense (Details)                                                
52: R78         Short-Term Borrowings, Long-Term Debt and           HTML    102K 
                Available Credit Facilities Short-term borrowings                
                and finance lease obligations (Details)                          
40: R79         Commitments and Contingent Liabilities Guarantee    HTML     42K 
                Narrative (Details)                                              
55: R80         Commitments and Contingent Liabilities Chemours     HTML     58K 
                (Details)                                                        
37: R81         Commitments and Contingent Liabilities DuPont       HTML     52K 
                (Details)                                                        
83: R82         Commitments and Contingent Liabilities PFOA /       HTML     73K 
                Leach Settlement (Details)                                       
121: R83         Commitments and Contingent Liabilities Other PFOA   HTML     50K  
                Matters / Fayetteville (Details)                                 
54: R84         Commitments and Contingent Liabilities              HTML     63K 
                Environmental (Details)                                          
36: R85         Stockholders' Equity Common Stock (Details)         HTML     64K 
82: R86         Stockholders' Equity Preferred Stock (Details)      HTML     49K 
120: R87         Stockholders' Equity Other Comprehensive Income     HTML     68K  
                (Loss) (Details)                                                 
51: R88         Stockholders' Equity Tax Benefit (Expense) on Net   HTML     40K 
                Activity (Details)                                               
39: R89         Stockholders' Equity Reclassifications out of AOCI  HTML     70K 
                (Details)                                                        
19: R90         Pension Plans and Other Post Employment Benefit     HTML     67K 
                Plans Components of net periodic benefit cost                    
                (Credit) (Details)                                               
61: R91         Financial Instruments Financial Instruments         HTML     39K 
                (Narrative) (Details)                                            
102: R92         Financial Instruments Notional Amounts (Details)    HTML     43K  
89: R93         Financial Instruments Cash Flow Hedges Included in  HTML     59K 
                AOCI (Details)                                                   
20: R94         Financial Instruments Fair Value of Derivatives     HTML     66K 
                (Details)                                                        
62: R95         Financial Instruments Effect of Derivative          HTML     65K 
                Instruments (Details)                                            
103: R96         Fair Value Measurements Fair Value Tables of        HTML     54K  
                Assets and Liabilities Measured on Recurring Basis               
                (Details)                                                        
90: R97         Segment Reporting Segment Information (Details)     HTML     54K 
17: R98         Segment Reporting Segment Reconciliation (Details)  HTML     67K 
65: R99         Segment Reporting Segment Asset Reconciliation      HTML     44K 
                (Details)                                                        
79: R100        Segment Reporting Significant Items (Details)       HTML     62K 
116: R101        EID - Basis of Presentation Narrative (Details)     HTML     44K  
58: R102        EID - Related Party Transactions (Details)          HTML     47K 
42: R103        EID Segment FN Segment reconciliation (Details)     HTML     75K 
46: XML         IDEA XML File -- Filing Summary                      XML    223K 
28: XML         XBRL Instance -- corteva-331202010xq_htm             XML   3.98M 
29: EXCEL       IDEA Workbook of Financial Reports                  XLSX    135K 
12: EX-101.CAL  XBRL Calculations -- dd-20200331_cal                 XML    192K 
13: EX-101.DEF  XBRL Definitions -- dd-20200331_def                  XML   1.52M 
14: EX-101.LAB  XBRL Labels -- dd-20200331_lab                       XML   2.12M 
15: EX-101.PRE  XBRL Presentations -- dd-20200331_pre                XML   1.67M 
11: EX-101.SCH  XBRL Schema -- dd-20200331                           XSD    263K 
123: JSON        XBRL Instance as JSON Data -- MetaLinks              472±   713K  
48: ZIP         XBRL Zipped Folder -- 0001755672-20-000014-xbrl      Zip    518K 


‘EX-10.4’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 10.4
AWARD TERMS OF
PERFORMANCE-BASED RESTRICTED STOCK UNITS GRANTED UNDER THE
CORTEVA, INC. 2019 OMNIBUS INCENTIVE PLAN
FOR GRANTEES LOCATED IN THE U.S.

Introduction
You have been granted performance-based Restricted Stock Units (“Units”) under the Corteva, Inc. 2019 Omnibus Incentive Plan (“Plan”), subject to the following Award Terms. This grant is also subject to the terms of the Plan, which is hereby incorporated by reference. However, to the extent that an Award Term conflicts with the Plan, the Plan shall govern. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in these Award Terms, including any appendices to these Award Terms (hereinafter, collectively referred to as the “Agreement”). A copy of the Plan, and other Plan-related materials, such as the Plan prospectus, are available at: www.benefits.ml.com

Grant Award
Acceptance
You must expressly accept the terms and conditions of your Award as set forth in this Agreement. To accept, log on to Merrill Lynch Benefits OnLine at www.benefits.ml.com, select Equity Plan > Grant Information > Pending Acceptance. If you do not accept your Units in the manner instructed by the Company, your Units will be subject to cancellation.
 
Date of Grant            DATE (“Date of Grant”)

Type of Award            Units

Dividend Equivalents
Dividends payable on the Shares represented by your Units (including whole and fractional Units) will be allocated to your account in the form of Units based upon the closing Share price on the date of the dividend payment. Such Units will be subject to the vesting terms set forth below and all other terms set forth in the Agreement. Dividend equivalent units will be determined after the end of the applicable performance period (“Performance Period”) and credited to your account at that time based on the performance-adjusted number of Units in your account. Dividend equivalent units will be calculated by taking the final performance-adjusted Units and calculating the dividend equivalent units for the first dividend payment date for the Performance Period. The resulting number of dividend equivalent units from the first dividend payment date will be added to the final performance-adjusted number of Units before calculating the dividend equivalent units for the second dividend payment date during the Performance Period. This process will be repeated for each subsequent dividend payment date during the Performance Period.

Performance Period
January [Year of Grant] - December [Year of Grant Plus Two Years]

Vesting Terms
You may not sell, gift, or otherwise transfer or dispose of any of the Units.

If you remain an active employee from the Date of Grant through the last day of the Performance Period, you will vest in the number of Units that become eligible to vest, if any, based on the achievement of the goals set forth in the Performance Metrics section set forth below. Except as set forth below, if you terminate employment after the Date of Grant but prior to the last day of the Performance Period, unvested Units will be forfeited.

Performance Metrics
The total number of Units subject to the Award that will be eligible to vest will be based upon the attainment level of the performance goals related to the Company’s (a)  Return on Invested Capital (“ROIC”) (as defined below) and (b) Operating Earnings Per Share (“EPS”) Growth (as defined below), in each case, during the Performance Period. The performance attainment level and percent of target payout will be determined independently for each metric, and the two metrics will be weighted differently in determining the final total number of Units that are eligible to vest (the “Final Award”). The ROIC performance goal is weighted at 50% and the Operating EPS Growth performance goal is weighted at 50%.






The Final Award is the sum of the following two elements:
ROIC Payout %
 x Target Award
x 50%
+
Operating EPS Growth Payout %
x Target Award
x 50%
=
Final Award

The ROIC Payout % and the Operating EPS Growth Payout % are set out below under the headings “ROIC Payout % Schedule” and “Operating EPS Growth Payout %” below.

1.ROIC Goal

“ROIC” is equal to Net Operating Profit After Tax (“NOPAT”), as described further below, divided by total debt plus equity, excluding goodwill and net intangibles as of the date the Company’s separation from DowDuPont Inc. became effective (the “Separation”).

The attainment level of the ROIC goal will be measured by adding the ROIC that is attained for each of the three fiscal years contained in the Performance Period and dividing this number by three (i.e., average ROIC attained over the Performance Period).

“NOPAT” is equal to Operating Earnings, as defined further below, less after-tax interest expense and after-tax interest income.

“Operating Earnings” means net income from continuing operations attributable to the Company, excluding the after-tax impact of significant items (including goodwill impairment charges), non-operating benefits - net, and amortization of intangible assets (existing as of the Separation).

ROIC Payout % Schedule

Performance
ROIC Average
(%)
ROIC Payout %
Below Threshold
 
 
Threshold
 
 
Target
 
 
Maximum
 
 
*Interim points are interpolated on a straight-line basis

Based on the table above, the Company’s average ROIC during the Performance Period is translated into a percentage payout (of the target) for 50% of the Units subject to the Award.

2.Operating EPS Growth Goal

“Operating Earnings Per Share” means, for a fiscal year within the Performance Period, Pro forma Operating Earnings (defined above), divided by the Diluted Shares Outstanding, rounded to the first decimal place.

“Diluted Shares Outstanding” means the number of Shares that are outstanding on a fully diluted basis as of the last day of the fiscal year contained in the Performance Period, as reported in the Company’s Form 10-K.

“Operating EPS Growth” for each of the fiscal years contained in the Performance Period shall be calculated in accordance with the following formula:








Operating EPS Growth = A / B x 100, where:

A =
Operating Earnings Per Share as reported at the end of a fiscal year, minus Operating Earnings Per Share as reported at the end of the prior fiscal year

B =
A / Operating Earnings Per Share as reported at the end of the prior fiscal year

The attainment level of the Operating EPS Growth goal will be measured by adding the Operating EPS Growth for each of the fiscal years that is contained in the Performance Period and dividing this number by 3 (i.e., average Operating EPS Growth over the Performance Period).

The payout percentage for each of the Performance Period will be determined in accordance with the Operating EPS Growth Payout Percentage Schedule set forth below.

Operating EPS Growth Payout % Schedule

Performance
Operating EPS Growth Average
Operating EPS Growth Payout %
Below Threshold
 
 
Threshold
 
 
Target
 
 
Maximum
 
 
*Interim points are interpolated on a straight-line basis

Based on the table above, the Company’s average Operating EPS Growth during the Performance Period is translated into a percentage payout (of the target) for 50% of the Units subject to the Award.
Performance
Adjustment
The Committee, in its sole and absolute discretion, may make appropriate and equitable adjustments to the performance goal measurement or the method applied to calculate such measurement or determine the underlying performance metric, in the event of or in connection with, among other items: (i) tax adjustments, (ii) a merger or acquisition or any similar event affecting the Shares or other securities of the Company, (iii) debt incurred relative to pension funding (whether required or driven by de-risking strategies), (iv) the impact of any new accounting standards, and (v) items associated with discontinued operations.

Payment
Within 70 days following the last day of the Performance Period, vested Units (including dividend equivalents accruing after the end of the Performance Period and prior to the payment date), if any, will be paid to you or your estate, as applicable, in one Share for each whole Unit and a cash payment for any fraction of a Unit. The value of each fractional Unit will be based on the average of the high and low sale prices of Shares as reported on the Composite Tape of the New York Stock Exchange as of the effective date of payment.






Section 409A of
the Code
The Units are intended to be exempt from or compliant with Section 409A of the Code and the U.S. Treasury Regulations relating thereto so as not to subject you to the payment of additional taxes and interest under Section 409A of the Code or other adverse tax consequences. In furtherance of this intent, the provisions of this Agreement will be interpreted, operated, and administered in a manner consistent with these intentions. The Committee may modify the terms of this Agreement, the Plan or both, without your consent, in the manner that the Committee may determine to be necessary or advisable in order to comply with Section 409A of the Code or to mitigate any additional tax, interest and/or penalties or other adverse tax consequences that may apply under Section 409A of the Code if compliance is not practical. This section does not create an obligation on the part of the Company to modify the terms of this Agreement or the Plan and does not guarantee that the Units or the delivery of Shares upon vesting/settlement of the Units will not be subject to taxes, interest and penalties or any other adverse tax consequences under Section 409A of the Code. In no event whatsoever shall the Company be liable to any party for any additional tax, interest or penalties that may be imposed on you by Section 409A of the Code or any damages for failing to comply with Section 409A of the Code.

Termination
of Employment
Under 55/10 Rule, Due to Disability or Death, Divestiture to Entity Less Than 50% Owned by the Company, or Involuntary Termination Giving Rise to Severance Benefits
 
If you are an active employee for six months following the Date of Grant and terminate employment (i) after attainment of age 55 with at least 10 years of service; or due to (ii) disability; (iii) death; (iv) liquidation, dissolution or divestiture to an entity less than 50% owned by the Company; or (v) an involuntary termination by the Company or, if different, your employer (the “Employer”) which gives rise to the payment of severance benefits under a plan maintained by the Company, the Units will remain subject to the Vesting Terms and will be paid in accordance with the Payment terms above. However, the number of Units will be prorated based on the number of months you were employed from the Date of Grant through the end of the Performance Period.
 
 
 
Due to Any Other Reason (including for Cause; Voluntary Termination; or Involuntary Termination Without Severance Benefits)
 
Units will be forfeited as of the date on which you terminate employment.

Restricted Conduct
If you engage in any of the conduct described in subparagraphs (i) through (v) below for any reason, in addition to all remedies in law and/or equity available to the Company or any Subsidiary or Affiliate, you shall forfeit all Units. For purposes of subparagraphs (i) through (v) below, “Company” shall mean Corteva, Inc. and/or any of its Subsidiaries or Affiliates.

(i) Confidential Information. During the course of your employment with the Company and thereafter, you use or disclose, except on behalf of the Company and pursuant to the Company’s directions, any Company “Confidential Information” (i.e., information concerning the Company and its business that is not generally known outside the Company, and includes, but is not limited to, (a) trade secrets; (b) intellectual property; (c) information regarding the Company’s present and/or future products, developments, processes and systems, including invention disclosures and patent applications; (d) information on customers or potential customers, including customers’ names, sales records, prices, and other terms of sales and Company cost information; (e) Company business plans, marketing plans, financial data and projections; and (f) information received in confidence by the Company from third parties. Information regarding products, services or technological innovations in development, in test marketing or being marketed or promoted in a discrete geographic region, which information the Company is considering for broader use, shall be deemed not generally known until such broader use is actually commercially implemented.); and/or

(ii) Solicitation of Employees. During your employment and for a period of one year following the termination of your employment for any reason, you hire, recruit, solicit or induce, or cause, allow, permit or aid others to hire, recruit, solicit or induce, any employee of the Company who possesses Confidential Information of the Company to terminate his/her employment with the Company and/or to seek employment with your new or prospective employer; and/or






(iii) Solicitation of Customers. During your employment and for a period of one year following the termination of your employment for any reason, you, directly or indirectly, on behalf of yourself or any other person, company or entity, solicit or participate in soliciting, products or services competitive with or similar to products or services offered by, manufactured by, designed by or distributed by the Company to any person, company or entity which was a customer or potential customer for such products or services and with which you had direct or indirect contact regarding those products or services or about which you learned Confidential Information at any time during the two years prior to your termination of employment with the Company; and/or

(iv) Non-Competition regarding Products or Services. During your employment and for a period of one year following the termination of your employment for any reason, you, directly or indirectly, in any capacity, provide products or services competitive with or similar to products or services offered by the Company to any person, company or entity which was a customer for such products or services and with which customer you had direct or indirect contact regarding those products or services or about which customer you learned Confidential Information at any time during the two years prior to your termination of employment with the Company; and/or

(v) Non-Competition regarding Activities. During your employment and for a period of one year following the termination of your employment for any reason, you engage in activities which are entirely or in part the same as or similar to activities in which you engaged at any time during the two years preceding termination of your employment with the Company for any person, company or entity in connection with products, services or technological developments (existing or planned) that are entirely or in part the same as, similar to, or competitive with, any products, services or technological developments (existing or planned) on which you worked at any time during the two years preceding termination of your employment. This paragraph applies in countries in which you have physically been present performing work for the Company at any time during the two years preceding termination of your employment.

Applicable Policies
This Award shall be subject to the Company’s clawback policy; the Corteva, Inc. Insider Trading Policy, including the anti-hedging and anti-pledging provisions thereunder; and/or share ownership guidelines, if any, (in each case as they may be amended from time to time), the terms of which are incorporated herein by reference.

Repayment/
Forfeiture
Any benefits you may receive hereunder shall be subject to repayment or forfeiture as may be required to comply with the requirements of the U.S. Securities and Exchange Commission or any applicable law, including the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act, or any securities exchange on which the Shares are traded, as may be in effect from time to time.

Withholding
You acknowledge that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to the Plan and legally applicable to you (“Tax-Related Items”) in connection with any aspect of the Units, including, but not limited to, the grant, vesting or settlement of the Units, the subsequent sale of Shares acquired pursuant to such settlement and the receipt of any dividends and/or any dividend equivalent units; and (2) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Units to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result. Further, if you are subject to Tax-Related Items in more than one jurisdiction, the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
    






Prior to any relevant taxable or tax withholding event, as applicable, you agree to make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax-Related Items. In this regard, you authorize the Company and/or the Employer, or their respective agents, at their discretion, to satisfy the obligations with regard to all Tax-Related Items by one or a combination of the following: (i) withholding from your wages or other cash compensation paid to you by the Company and/or the Employer; or (ii) withholding from proceeds of the sale of Shares acquired upon settlement of the Units either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization without further consent); or (iii) withholding in Shares to be issued upon settlement of the Unit; or (iv) any other method of withholding determined by the Company and to the extent required by Applicable Law or the Plan, approved by the Committee; provided, however, that if you are subject to the short-swing profit rules of Section 16(b) of the Exchange Act, then the Company will withhold in Shares upon the relevant taxable or tax withholding event unless otherwise determined by the Committee.

The Company may withhold or account for Tax-Related Items by considering applicable statutory withholding rates, up to and including maximum applicable rates, in the jurisdictions applicable to you, in which case, you may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent in Shares. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes, you are deemed to have been issued the full number of Shares subject to the vested Units, notwithstanding that a number of the Shares are held back solely for the purpose of paying the Tax-Related Items.
    
Finally, you agree to pay to the Company or the Employer, any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the shares or the proceeds of the sale of Shares, if you fail to comply with your obligations in connection with the Tax-Related Items.

Notwithstanding anything in this section to the contrary, to avoid a prohibited acceleration under Section 409A of the Code, if Shares subject to the Units will be withheld (or sold on your behalf) to satisfy any Tax Related Items arising prior to the date of settlement of the Units for any portion of the Units that is considered nonqualified deferred compensation subject to Section 409A of the Code, then the number of shares withheld (or sold on your behalf) shall not exceed the number of shares that equals the liability for Tax-Related Items.

Severability
The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.

Waiver
You acknowledge that a waiver by the Company or breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by you or any other participant.

Privacy
In relation to this Agreement, the Company may collect, use, transfer and share your personal information, such as your name, contact information and banking information. The Company may share personal information with its Affiliates and selected third parties outside of your country of residence, including the United States, which may have data protection rules that are different from those of your country, to perform this Agreement and for purposes consistent with our privacy statement: https://www.corteva.com/privacy.html.






Insider Trading/
Market Abuse Laws
You may be subject to insider trading restrictions and/or market abuse laws based on the exchange on which the Shares are listed and in applicable jurisdictions including the United States and your country or your broker's country, if different, which may affect your ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., Units) or rights linked to the value of Shares under the Plan during such times as you are considered to have "inside information" regarding the Company (as defined by Applicable Laws). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed inside information. Furthermore, you could be prohibited from (a) disclosing the inside information to any third party and (b) "tipping" third parties or causing them otherwise to buy or sell securities. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under the Corteva, Inc Insider Trading Policy. You acknowledge that it is your responsibility to comply with any applicable restrictions, and you should speak to your personal advisor on this matter.

Imposition of
Other Requirements
The Company reserves the right to impose other requirements on your participation in this Agreement, on the Units and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.





Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/7/20None on these Dates
For Period end:3/31/20
 List all Filings 


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/08/24  Corteva, Inc.                     10-K       12/31/23  176:25M
 2/09/23  Corteva, Inc.                     10-K       12/31/22  166:28M
 2/10/22  Corteva, Inc.                     10-K       12/31/21  187:29M
 2/11/21  Corteva, Inc.                     10-K       12/31/20  196:32M
11/05/20  Corteva, Inc.                     S-8        11/05/20    6:168K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001755672-20-000014   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 5:07:05.1pm ET